↓ Skip to main content

GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus

Overview of attention for article published in New England Journal of Medicine, February 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
14 X users
patent
9 patents
facebook
5 Facebook pages
f1000
1 research highlight platform

Citations

dimensions_citation
274 Dimensions

Readers on

mendeley
173 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
GAD65 Antigen Therapy in Recently Diagnosed Type 1 Diabetes Mellitus
Published in
New England Journal of Medicine, February 2012
DOI 10.1056/nejmoa1107096
Pubmed ID
Authors

Johnny Ludvigsson, David Krisky, Rosaura Casas, Tadej Battelino, Luis Castaño, James Greening, Olga Kordonouri, Timo Otonkoski, Paolo Pozzilli, Jean-Jacques Robert, Henk J Veeze, Jerry Palmer, Ulf Samuelsson, Helena Elding Larsson, Jan Åman, Gunilla Kärdell, Jan Neiderud Helsingborg, Göran Lundström, Eva Albinsson, Annelie Carlsson, Maria Nordvall, Hans Fors, Carl-Göran Arvidsson, Stig Edvardson, Ragnar Hanås, Karin Larsson, Björn Rathsman, Henrik Forsgren, Helena Desaix, Gun Forsander, Nils-Östen Nilsson, Carl-Göran Åkesson, Päivi Keskinen, Riitta Veijola, Timo Talvitie, Klemens Raile, Thomas Kapellen, Walter Burger, Andreas Neu, Ilse Engelsberger, Bettina Heidtmann, Suzanne Bechtold, David Leslie, Francesco Chiarelli, Alesandro Cicognani, Giuseppe Chiumello, Franco Cerutti, Gian Vincenzo Zuccotti, Ana Gomez Gila, Itxaso Rica, Raquel Barrio, Maria Clemente, Maria José López Garcia, Mercedes Rodriguez, Isabel Gonzalez, Juan Pedro Lopez, Mirentxu Oyarzabal, H M Reeser, Roos Nuboer, Pauline Stouthart, Natasa Bratina, Nina Bratanic, Marc de Kerdanet, Jacques Weill, Nicole Ser, Pascal Barat, Anne Marie Bertrand, Jean-Claude Carel, Rachel Reynaud, Regis Coutant, Sabine Baron

Abstract

The 65-kD isoform of glutamic acid decarboxylase (GAD65) is a major autoantigen in type 1 diabetes. We hypothesized that alum-formulated GAD65 (GAD-alum) can preserve beta-cell function in patients with recent-onset type 1 diabetes.

X Demographics

X Demographics

The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 173 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 2%
Italy 2 1%
Netherlands 1 <1%
New Zealand 1 <1%
Sweden 1 <1%
Spain 1 <1%
Denmark 1 <1%
Unknown 163 94%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 30 17%
Student > Ph. D. Student 25 14%
Researcher 23 13%
Student > Master 23 13%
Other 12 7%
Other 38 22%
Unknown 22 13%
Readers by discipline Count As %
Medicine and Dentistry 69 40%
Agricultural and Biological Sciences 20 12%
Biochemistry, Genetics and Molecular Biology 16 9%
Immunology and Microbiology 14 8%
Nursing and Health Professions 8 5%
Other 21 12%
Unknown 25 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 20. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 September 2023.
All research outputs
#1,845,911
of 25,382,250 outputs
Outputs from New England Journal of Medicine
#13,077
of 32,443 outputs
Outputs of similar age
#13,170
of 257,694 outputs
Outputs of similar age from New England Journal of Medicine
#152
of 288 outputs
Altmetric has tracked 25,382,250 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,443 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 121.9. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 257,694 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 288 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.